Cirdan joins over 20 Leading UK HealthTech Innovators on ABHI Mission to strengthen trade partnerships in Tennessee

Bronagh McStravick

25th Jul 2022
Cirdan joins over 20 Leading UK HealthTech Innovators on ABHI Mission to strengthen trade partnerships in Tennessee

Cirdan is delighted to be among the delegate of leading UK HealthTech innovators heading to Tennessee this week (25th-29th July 2022) to strengthen trade links and showcase its products and services to the US market.

The visit marks the second major US trade mission organised this year by the Association of British HealthTech Industries (ABHI) as part of its flagship US Accelerator programme.


The missions – exclusive to members of the ABHI US Accelerator – aim to provide participants with access to senior leaders, clinicians, and procurement teams from world-class hospital systems in the US, supporting them in engaging the right stakeholders and explore key markets.


Along with a cohort of over 20 companies, Cirdan will be showcasing its latest products and innovations, which are enhancing clinical laboratory workflows, ultimately improving patient outcomes and diagnosis across the globe.

In the US Tennessee is renowned as a life sciences powerhouse – and ranks second in the nation in exports of medical equipment and supplies, with a total of $4.0 billion in 2020.

ABHI’s week-long mission will introduce members to the leaders from across this dynamic ecosystem, including hospital systems, accelerators, business chambers and professional service companies.

The visit will provide a prime opportunity for members to explore the strengths of two its biggest cities, Memphis and Nashville – home to world-renowned research institutions and a cluster of innovative companies. Ideal for UK HealthTech companies that are keen to develop and strengthen trade partnerships across the State, the mission aims to generate further demand for UK-developed products.

Philip Moore, Head of Sales at Cirdan, commented, “Cirdan is delighted to be among the UK HealthTech pioneers joining the ABHI trade mission to Tennessee. The ABHI mission offers a unique opportunity to meet with leading healthcare providers face-to-face and introduce the benefits that Cirdan can bring to their workplace, revolutionising clinical pathology workflows. This furthers our mission to strengthen relationships with key stakeholders in the US.”

Centred in Texas, the ABHI US Accelerator is delivered in partnership with the Dell Medical School, one of the United States’ most pioneering academic institutions, based at the University of Texas, in Austin. Using the state as a springboard to other key states, the programme offers nationwide support, drawing on the relationships and connections ABHI has cultivated across the US.

Central to the 12-month programme is ABHI’s calendar of trade missions, which take place throughout the year, taking members to key states across the US, enabling them to explore new markets, minimise risk, meet new customers and gain valuable market insight.

The upcoming trade mission will allow participants to explore Tennessee’s burgeoning healthcare and technology sector. The region is home to world-class systems and hospitals, supported by world-class research capabilities, and is renowned for housing a greater employment concentration for the healthcare and medical devices sector compared to both the Southeast and the US.

In addition, it is the birthplace of HCA – the world’s largest private hospital group – offering a vast number of opportunities for UK HealthTech innovators and entrepreneurs looking to tap into this flourishing ecosystem.

The cohort of companies taking part in the visit will be showcasing a range of UK HealthTech products and solutions. Throughout the week, meetings will take place with senior leadership from hospital systems, group purchasing organizations (GPOs), distributors, investors and procurement teams across Nashville and Memphis. The mission will incorporate a series of group meetings, networking events, working groups and introductions to a range of supporting organisations, including the Nashville Area Chamber of Commerce, Greater Nashville Technology Council, as well as the senior leadership teams from HCA Healthcare and Ascension Saint Thomas Hospital.

Throughout the rest of the year, participants of this year’s ABHI US Accelerator will also take part in missions to other key states, taking them as far wide as Minnesota, Florida and Boston, where this year’s MedTech Conference is being held.

Paul Benton, Managing Director, International, ABHI commented: “The healthcare industry in Tennessee is a juggernaut that deserves a greater share of voice when compared to other parts of the country. We are looking forward to bringing back some of the UK’s leading healthcare innovators and clinicians to this vibrant state in July. Tennessee boasts a significant presence from world-leading systems and hospitals, and the scale of this health economy has driven an influx of entrepreneurs and investment in recent years. Our visit will accordingly give our members a chance to explore the ample opportunities for collaboration and partnership in the region and showcase what the UK’s HealthTech community has to offer.”

For more information, visit:

About ABHI

ABHI is the UK’s leading industry association for health technology (HealthTech).

ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is the largest employer in the broader Life Sciences sector, employing 138,100 people in 4,140 companies, with a combined turnover of £27.6bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 320 members account for approximately 80% of the sector by value.